{
    "url_original": "https://www.wsj.com/articles/regenerons-antibody-drug-cut-risk-of-covid-19-by-82-company-says-11636385459?mod=business_lead_pos1",
    "url": "regenerons-antibody-drug-cut-risk-of-covid-19-by-82-company-says-11636385459",
    "title": "Regeneron’s Antibody Drug Cut Risk of Covid-19 by 82%, Company Says",
    "sub_head": "Data suggest potential use for drug as a prophylactic for the immunocompromised or others who aren’t well protected by vaccination",
    "category_1": "Business",
    "category_2": "Health Care",
    "image_1_url": "https://images.wsj.net/im-430953?width=860&height=573",
    "image_1": "im-430953.jpg",
    "time": "2021-11-08 10:31:00"
}